[Influence of TORCH-infections on the spermatogenesis of men].
The purpose of the given study was to reveal causal relations between infection of the urino-genital tract by intracellular parasites, the so-called TORCH-infections, and the decrease of spermatogenesis. For observation 182 men of reproductive age (from 22 to 38 years) with oligozoospermia and aspermia, without any complaints or clinical symptoms indicating existence of infections of urino-genital tracts, were selected. Out of those, 131 revealed oligozoospermia, i.e. the quantity of spermatozoons was no higher than 20 mln in 1 ml of ejaculate, and 51 revealed - aspermia. For examination of some TORCH infections, medical doctors in charge directed 44 oligozoospermia patients and 15 aspermia patients, who respectively constituted group I and group II. Examinations were carried out for Chlamydia trachomatis--(Ch.t), Herpes simplex virus--(HSV), Ureaplasma urealiticum--(U.u.), Cytomegalovirus--(CMV), and Mycoplasma hominis--(M.h.). In the group with oligozoospermia, cases of infections by Chlamydias (41.5%) and Herpes virus (51.3%) were frequent, but Ureaplasma (56,5%) was more frequent than any infections. Cytomegalovirus occurred in the least number of cases. Making any conclusions on the frequency of infections by M.h. is difficult due to the low number of examinations. Similar picture was observed in Group II as well. Following successful treatment of infections in Group I, 8 patients with Ch.t. and 8 patients with U.u. showed an improved spermogram after several months. Treatment of other infections did not yield tangible results. In Group II spermatogenesis remained without any changes.
Tbilisi State Medical University, Department of Laboratory Medicine.
T Sh
TSh
Bukia
L Sh
LSh
Shanidze
K G
KG
Maisuradze
D000328:Adult; D053714:Aspermia / Q000188:drug therapy / Q000382:microbiology* / Q000821:virology; D002690:Chlamydia Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D006561:Herpes Simplex / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008297:Male; D009175:Mycoplasma Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D019535:Mycoplasma hominis / Q000302:isolation & purification; D009845:Oligospermia / Q000188:drug therapy / Q000382:microbiology* / Q000821:virology; D012409:Rubella / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D013091:Spermatogenesis; D014123:Toxoplasmosis / Q000150:complications / Q000503:physiopathology; D016869:Ureaplasma Infections / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D016990:Ureaplasma urealyticum / Q000302:isolation & purification; D055815:Young Adult